RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Samsung Biologics Co - Stock

Samsung Biologics Co Revenue 2024

Samsung Biologics Co Revenue

4.17 T KRW

Ticker

207940.KS

ISIN

KR7207940008

WKN

A2AUB1

In 2024, Samsung Biologics Co's sales reached 4.17 T KRW, a 12.93% difference from the 3.69 T KRW sales recorded in the previous year.

The Samsung Biologics Co Revenue history

YEARREVENUE (undefined KRW)GROSS MARGIN (%)
2026e5.5732,37
2025e4.8337,33
2024e4.1743,21
20233.6948,79
2022348,93
20211.5746,33
20201.1635,72
20190.727,37
20180.5427,09
20170.4628,37
20160.299,01
20150.09-25,75
20140.11-18,75
20130.02-217,74

Samsung Biologics Co Aktienanalyse

What does Samsung Biologics Co do?

Samsung Biologics Co Ltd is a biotechnology company based in South Korea. The company was founded in 2011 by Samsung Group and has since become one of the world's leading providers of biopharmaceutical manufacturing services. Samsung Biologics aims to improve the conduct of clinical studies by providing top-quality biopharmaceutical products and services. The business model of Samsung Biologics is to manufacture biopharmaceuticals for internationally leading pharmaceutical and biotechnology companies. The company offers a wide range of services, including cell line development, process development, and production processes. Samsung Biologics Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Samsung Biologics Co's Sales Figures

The sales figures of Samsung Biologics Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Samsung Biologics Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Samsung Biologics Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Samsung Biologics Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Samsung Biologics Co Stock

How much revenue did Samsung Biologics Co generate this year?

Samsung Biologics Co has achieved a revenue of 4.17 T KRW this year.

How much was the turnover of the company Samsung Biologics Co compared to the previous year?

The revenue of Samsung Biologics Co has increased by 12.93% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Samsung Biologics Co?

The revenue of Samsung Biologics Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Samsung Biologics Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Samsung Biologics Co so important for investors?

The revenue of Samsung Biologics Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Samsung Biologics Co pay?

Over the past 12 months, Samsung Biologics Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Samsung Biologics Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Samsung Biologics Co?

The current dividend yield of Samsung Biologics Co is .

When does Samsung Biologics Co pay dividends?

Samsung Biologics Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Samsung Biologics Co?

Samsung Biologics Co paid dividends every year for the past 0 years.

What is the dividend of Samsung Biologics Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Samsung Biologics Co located?

Samsung Biologics Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Samsung Biologics Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Samsung Biologics Co from 6/11/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.

When did Samsung Biologics Co pay the last dividend?

The last dividend was paid out on 6/11/2024.

What was the dividend of Samsung Biologics Co in the year 2023?

In the year 2023, Samsung Biologics Co distributed 0 KRW as dividends.

In which currency does Samsung Biologics Co pay out the dividend?

The dividends of Samsung Biologics Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Samsung Biologics Co

Our stock analysis for Samsung Biologics Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Samsung Biologics Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.